2004
DOI: 10.1590/s1806-37132004000100013
|View full text |Cite
|
Sign up to set email alerts
|

Linfangioleiomiomatose pulmonar

Abstract: Lymphangioleiomyomatosis (LAM) is a rare lung disease of unknown etiology that primarily affects women of childbearing age. Clinically, it manifests as progressive dyspnea, hemoptysis, pneumothorax and chylous pleural effusion resulting from abnormal smooth muscle proliferation in the lung parenchyma, lymph nodes, small airways and blood vessels. Recent cytogenetic studies have disclosed mutations of the tuberous sclerosis complex (TSC)-2 gene in cells of renal angiomyolipoma and in abdominal lymph nodes, poin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 42 publications
(47 reference statements)
0
2
0
Order By: Relevance
“…Twenty‐five of them had been diagnosed as having idiopathic pulmonary fibrosis (IPF), 6 patients had chronic hypersensitivity pneumonitis (CHP), 5 patients had centrilobular fibrosis secondary to gastroesophageal reflux disease (GERD), and 15 patients received the diagnosis of lymphangioleiomyomatosis (LAM). 15 , 16 …”
Section: Methodsmentioning
confidence: 99%
“…Twenty‐five of them had been diagnosed as having idiopathic pulmonary fibrosis (IPF), 6 patients had chronic hypersensitivity pneumonitis (CHP), 5 patients had centrilobular fibrosis secondary to gastroesophageal reflux disease (GERD), and 15 patients received the diagnosis of lymphangioleiomyomatosis (LAM). 15 , 16 …”
Section: Methodsmentioning
confidence: 99%
“…The sporadic form is responsible for most cases, with an estimated prevalence of approximately 3.3 to 7.7 per 1,000,000 women [ 2 , 3 ]. Tuberous sclerosis is a dominant autosomal disease, associated with the suppressor oncogenes TSC-1 in chromosome 9, and TSC-2 in chromosome 16, and mutations in their alleles may lead to cellular proliferation [ 4 ]. It is estimated that about 80% of women with TSC will present pulmonary cysts in the follow-up [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…É comum ocorrer a conclusão do diagnóstico da LAM em torno de 30 a 40 anos de idade da paciente, frequentemente anos depois do início dos sintomas 6 . Junior e Carvalho (2004) 4 40,41 .…”
Section: Quadro Clínico Na Lamunclassified